The North America oxygen concentrators market size was exhibited at USD 1.46 billion in 2022 and is projected to hit around USD 4.12 billion by 2032, growing at a CAGR of 10.9% during the forecast period 2023 to 2032.
Key Pointers:
Report Scope of the North America oxygen concentrators Market
Report Coverage |
Details |
Market Size in 2023 |
USD 1.62 Billion |
Market Size by 2032 |
USD 4.12 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 10.9% |
Base Year |
2022 |
Forecast Period |
2023 to 2032 |
Segments Covered |
Product, application, technology, region |
Key companies profiled |
Invacare Corporation; Philips Healthcare; AirSep Corporation; DeVilbiss Healthcare; Nidek Medical Products, Inc.; Inogen, Inc.; Inova Labs, Inc.; O2 Concepts |
The growing prevalence of Chronic Obstructive Pulmonary Disease (COPD) along with other lung diseases is a major parameter driving the market. According to the Centers for Disease Control and Prevention, 9 million people suffered from chronic bronchitis and 3.8 million from emphysema in 2018 in the U.S. Moreover, 3.8 million people in Canada had asthma and 2.0 million people had COPD in 2018, according to the Government of Canada. The use of supplemental oxygen increases the survival rate of COPD patients. Thus, the increasing dependence of COPD patients on O2 concentrators is driving the market.
The increasing number of initiatives to promote awareness of lung diseases as well as the importance of O2 generators are contributing to the growth of the market. For instance, the American Lung Association works to create awareness of COPD and increase federal funding for research and development. Furthermore, the National Institute of Health sponsors a nationwide awareness campaign “Learn More, Breathe Better”, which encourages the population over the age of 45 years who are at risk of experiencing symptoms of COPD to have a diagnostic breathing test, and consult the medical professionals for treatment options. Moreover, technological advancements and the easy availability of a large variety of O2 concentrators are driving the market. For instance, in July 2020, GCE introduced a series of Fixed Medical Oxygen Concentrators including M50, EC-E100, and OC-E 80 for patients requiring long-term oxygen therapy.
The sudden outbreak of the COVID-19 pandemic has increased the demand for respiratory care products. Low blood oxygen level is one of the effects of COVID-19 and patients require oxygen support for recovery. Additionally, the U.S. Food and Drug Administration has allowed the usage of O2 generators under the Emergency Use Authorization scheme. This, in turn, is estimated to drive the market.
According to the National Health Expenditure Accounts (NHEA), healthcare spending in the U.S. increased by 4.6% in 2019 and was estimated at US$ 3.8 trillion. The per-person expenditure in 2019 was USD 11,582 and contributed to 17.7% of the GDP. Moreover, the healthcare expenditure in Canada was US$ 265.5 billion, according to the Canadian Institute of Health Information. The rise in healthcare spending is estimated to trigger the need for effective diagnosis and treatment of respiratory diseases. This, in turn, is estimated to reinforce the demand for oxygen concentrators.
Supporting initiatives by the public and private authorities is driving the market. For instance, as of February 2022, the World Health Organization has distributed 30,000 oxygen concentrators globally. In February 2022, 3B Medical announced that it will donate Aer X portable concentrator each month for the next six months. In March 2022, the U.S. Food and Drug Administration granted 510(k) clearance and marketing authorization for the X-PLO2R portable oxygen concentrator of Belluscura. Moreover, various associations such as the American Lung Association, and the National Heart, Lung, and Blood Institute (NHLBI), among others, are working towards increasing awareness of respiratory diseases such as COPD.
North America oxygen concentrators Market Segmentation And Regions
By Product Type | By Application | By Technology | Regions Covered |
Portable Medical Oxygen Concentrators Fixed Medical Oxygen Concentrators |
Homecare Non-Homecare |
Continuous Flow Pulse Flow |
North America U.S. Canada |
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 Nova one advisor’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 North America Oxygen Concentrators Market Outlook
2.2 North America Oxygen Concentrators Market Segment Outlook
2.3 North America Oxygen Concentrators Market Competitive Insight
2.4 North America Oxygen Concentrators Snapshot
Chapter 3 North America Oxygen Concentrators Market Variables, Trends, & Scope
3.1 Oxygen Concentrators Market Snapshot
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 North America Oxygen Concentrators Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.5 Oxygen Concentrators Competitive Landscape: Market Position Analysis
3.6 Medical Oxygen Concentrator Market: Product Pipeline Analysis
3.7 Medical Oxygen Concentrator Market: Medicare Claim Data
3.8 North America Fixed Medical Oxygen Concentrators Market Share
3.9 North America Portable medical oxygen concentrators market Share Analysis
Chapter 4 North America Oxygen Concentrators Market: Product Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 North America Oxygen Concentrators Market: Product Market Share Analysis, 2023 and 2032
4.3 Portable medical oxygen concentrators
4.3.1 Portable medical oxygen concentrators market estimates and forecasts, 2020 - 2032
4.4 Fixed Medical Oxygen Concentrators
4.4.1 Fixed Medical Oxygen Concentrators market estimates and forecasts, 2020 - 2032
Chapter 5 North America Oxygen Concentrators Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 North America Oxygen Concentrators Market: Application Market Share Analysis
5.3 Home care
5.3.1 Home care market estimates and forecasts, 2020 - 2032
5.4 Non home care
5.4.1 Non home care market estimates and forecasts, 2020 - 2032
Chapter 6 North America Oxygen Concentrators Market: Technology Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 North America Oxygen Concentrators Market: Technology Market Share Analysis
6.3 Pulse Flow Technology
6.3.1 Pulse Flow technology market estimates and forecasts, 2020 - 2032
6.4 Continuous Flow Technology
6.4.1 Continuous flow technology market estimates and forecasts, 2020 - 2032
Chapter 7 North America Oxygen Concentrators Market: Regional Estimates & Trend Analysis, By Product, Application, and Technology
7.1 North America Oxygen Concentrators Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Oxygen Concentrators Market Estimates and Forecasts, By Product, Application, and Technology, 2020 - 2032
7.2.2 U.S.
7.2.2.1 U.S. Oxygen Concentrators Market Estimates and Forecasts, By Product, Application, and Technology, 2020 - 2032
7.2.3 Canada
7.2.3.1 Canada Oxygen Concentrators Market Estimates and Forecasts, By Product, Application, and Technology, 2020 - 2032
Chapter 8 Competitive Landscape
8.1 Invacare Corporation
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Koninklijke Philips N.V.
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 AirSep Corporation
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 DeVilbiss Healthcare LLC
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Nidek Medical Products, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Inogen
8.6.1 Company overview
8.6.2 Financial performance
8.6.4 Product benchmarking
8.6.4 Strategic initiatives
8.7 Inova Labs Inc.
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 O2 Concepts, LLC
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives